We are live on ! Find out more
ACM

Ayer Capital Management Portfolio holdings

AUM $26.8M
This Fund
S&P 500
This Quarter Est. Return
+36.53%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$68.3M
AUM Growth
Cap. Flow
+$63.5M
Cap. Flow %
93.05%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOVA icon
1
Iovance Biotherapeutics
IOVA
$1.82B
$67.9M 99.4%
+5,604,015
New +$63.1M
CASC
2
DELISTED
Cascadian Therapeutics, Inc.
CASC
$407K 0.6%
+41,667
New +$409K

Similar funds

Ayer Capital Management's Q1 2015 Portfolio in Review

Q1 2015 is the first quarter with a 13F filing on record for Ayer Capital Management, which disclosed 2 positions worth $68.3M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Iovance Biotherapeutics: 5,604,015 shares worth $67.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Ayer Capital Management's largest Q1 2015 buy was Iovance Biotherapeutics: 5,604,015 shares worth $67.9M.
  • Ayer Capital Management's ten largest holdings make up 100% of its $68.3M portfolio in Q1 2015.
  • Ayer Capital Management disclosed 2 positions in Q1 2015, its first 13F filing on record.

Based on Ayer Capital Management's 13F filing for Q1 2015, filed 20 May 2015.